The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.

Abstract:

:Glucocorticoids (GC) are used for the treatment of a wide spectrum of diseases because of their potent anti-inflammatory and immunosuppressive effects, and they are serious and common causes of secondary osteoporosis. Administration of intermittent parathyroid hormone (PTH) may induce formation of new bone and may counteract the bone loss induced by GC treatment. Effects of simultaneous PTH and GC treatment were investigated on bone biomechanics, static and dynamic histomorphometry, and bone metabolism. Twenty-seven-month-old female rats were divided randomly into the following groups: baseline, vehicle, PTH, GC, and PTH + GC. PTH (1-34) 25 mug/kg and GC (methylprednisolone) 2.5 mg/kg were injected subcutaneously each day for a treatment period of 8 weeks. The rats were labeled with fluorochromes 3 times during the experiment. Bone sections were studied by fluorescence microscopy. The PTH injections resulted in a 5-fold increase in cancellous bone volume. At the proximal tibia, PTH induced a pronounced formation of new cancellous bone which originated from the endocortical bone surfaces and from thin trabeculae. Formation and modeling of connections between trabeculae were observed. Similar but less pronounced structural changes were seen in the PTH + GC group. The compressive strength of the cancellous bone was increased by 6-fold in the PTH group compared with the vehicle group. GC partially inhibited the increase in compressive strength induced by PTH. Concerning cortical bone, PTH induced a pronounced increase in the endocortical bone formation rate (BFR) and a smaller increase in periosteal BFR. The combination of PTH + GC resulted in a partial inhibition of the PTH-induced increase in bone formation. Serum-osteocalcin was increased by 65% in the PTH group and reduced by 39% in the GC group. The pronounced anabolic effect of PTH injections on the endocortical and trabecular bone surfaces and less pronounced anabolic effect on periosteal surfaces were partially inhibited, but not prevented, by simultaneous GC treatment in old rats. Both cortical and cancellous bone possessed full mechanical competence after treatment with PTH + GC.

journal_name

Bone

journal_title

Bone

authors

Oxlund H,Ortoft G,Thomsen JS,Danielsen CC,Ejersted C,Andreassen TT

doi

10.1016/j.bone.2006.01.142

subject

Has Abstract

pub_date

2006-08-01 00:00:00

pages

244-52

issue

2

eissn

8756-3282

issn

1873-2763

pii

S8756-3282(06)00193-1

journal_volume

39

pub_type

杂志文章

相关文献

BONE文献大全
  • Functional analysis of bone sialoprotein: identification of the hydroxyapatite-nucleating and cell-binding domains by recombinant peptide expression and site-directed mutagenesis.

    abstract::Mammalian bone sialoprotein (BSP) is a mineralized tissue-specific protein containing an RGD (arginine-glycine-aspartic acid) cell-attachment sequence and two distinct glutamic acid (glu)-rich regions, with each containing one contiguous glu sequence. These regions have been proposed to contribute to the attachment of...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(00)00392-6

    authors: Harris NL,Rattray KR,Tye CE,Underhill TM,Somerman MJ,D'Errico JA,Chambers AF,Hunter GK,Goldberg HA

    更新日期:2000-12-01 00:00:00

  • A theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment.

    abstract::In patients with osteoporosis, alendronate treatment causes an increase in bone mineral density (BMD) and a decrease in fracture incidence. Alendronate acts by changing the bone remodeling process. Changes in bone remodeling resulting in decreased remodeling space, increased bone balance per remodeling cycle, and incr...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(01)00613-5

    authors: Hernandez CJ,Beaupré GS,Marcus R,Carter DR

    更新日期:2001-12-01 00:00:00

  • The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling.

    abstract:OBJECTIVE:Type IIB procollagen is characteristic of cartilage, comprising 50% of the extracellular matrix. The NH(2)-propeptide of type IIB collagen, PIIBNP, can kill tumor cells via binding to integrins α(V)β(3) and α(V)β(5). As osteoclasts rely on α(V)β(3) integrins for function in bone erosion, we sought to determin...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.06.011

    authors: Hayashi S,Wang Z,Bryan J,Kobayashi C,Faccio R,Sandell LJ

    更新日期:2011-10-01 00:00:00

  • Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs).

    abstract::Adipose-derived adult stem cells (ASCs), like their bone-marrow derived counterparts, possess the ability to differentiate down osteogenic, chondrogenic, adipogenic, and myogenic pathways. For bone differentiation of mouse ASCs (mASCs), retinoic-acid mediated upregulation of BMPR-IB has been found to be necessary. Int...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.01.026

    authors: Quarto N,Wan DC,Longaker MT

    更新日期:2008-06-01 00:00:00

  • Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited.

    abstract::Osteocytes are cells buried in the bone matrix. They largely contribute to the regulation of bone remodeling in response to mechanical and microenvironmental changes. Much has been recognized in recent years regarding the role of osteocytes in bone homeostasis, nevertheless their ability to directly contribute to mine...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2008.09.017

    authors: Teti A,Zallone A

    更新日期:2009-01-01 00:00:00

  • Effective intervention of low peak bone mass and bone modeling in the spontaneous murine model of senile osteoporosis, SAM-P/6, by Ca supplement and hormone treatment.

    abstract::SAM-P/6 is a recently developed strain of osteoporotic mice. In this study we tried to determine whether calcium, vitamin D3, parathyroid hormone (PTH), and estrogen modified the peak bone mass of young SAM-P/6 mice, and whether the effect of these medications persisted after treatment had been discontinued. Calcium s...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(94)90710-2

    authors: Takahashi K,Tsuboyama T,Matsushita M,Kasai R,Okumura H,Yamamuro T,Okamoto Y,Kitagawa K,Takeda T

    更新日期:1994-03-01 00:00:00

  • Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats.

    abstract::Vitamin K may be important in bone metabolism. Notably, high-dose menaquinone-4 (menatetrenone, MK4) has been reported to reduce ovariectomy (ovx)-induced bone loss in rats and to decrease osteoporotic fracture in postmenopausal women. However, it is unclear whether these beneficial effects reflect a physiologic effec...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00734-2

    authors: Binkley N,Krueger D,Engelke J,Crenshaw T,Suttie J

    更新日期:2002-06-01 00:00:00

  • The effect of static bone strain on implant stability and bone remodeling.

    abstract::Bone remodeling is a process involving both dynamic and static bone strain. Although there exist numerous studies on the effect of dynamic strain on implant stability and bone remodeling, the effect of static strain has yet to be clarified. Hence, for this purpose, the effect of static bone strain on implant stability...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.07.003

    authors: Halldin A,Jimbo R,Johansson CB,Wennerberg A,Jacobsson M,Albrektsson T,Hansson S

    更新日期:2011-10-01 00:00:00

  • Investigating the role of the growth hormone-insulin-like growth factor (GH-IGF) axis as a determinant of male bone mineral density (BMD).

    abstract:INTRODUCTION:The GH-IGF axis has profound effects on bone metabolism and may be important in the etiology of idiopathic osteoporosis. Serum IGF-I is often low in men with osteoporosis, which may be attributable to GH hypo-secretion or hepatic GH insensitivity. We studied the GH-IGF axis in depth to look for evidence to...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.06.016

    authors: Patel MB,Arden NK,Masterson LM,Phillips DI,Swaminathan R,Syddall HE,Byrne CD,Wood PJ,Cooper C,Holt RI,Hertfordshire Cohort Study Group.

    更新日期:2005-12-01 00:00:00

  • Safety of bisphosphonates.

    abstract::Bisphosphonates are one of the most well studied groups of medications and they are bone specific. This tissue specificity is a rare property for a drug introduced into clinical practice as long as 40 years ago. Over the years, the therapeutic boundaries of bisphosphonates were explored and their safety profile has wi...

    journal_title:Bone

    pub_type: 杂志文章,评审

    doi:10.1016/j.bone.2011.01.003

    authors: Pazianas M,Abrahamsen B

    更新日期:2011-07-01 00:00:00

  • Identification of material parameters based on Mohr-Coulomb failure criterion for bisphosphonate treated canine vertebral cancellous bone.

    abstract::Nanoindentation has been widely used to study bone tissue mechanical properties. The common method and equations for analyzing nanoindentation, developed by Oliver and Pharr, are based on the assumption that the material is linearly elastic. In the present study, we adjusted the constraint of linearly elastic behavior...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.05.023

    authors: Wang X,Allen MR,Burr DB,Lavernia EJ,Jeremić B,Fyhrie DP

    更新日期:2008-10-01 00:00:00

  • Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.

    abstract::Androgen receptor (AR) is expressed throughout the osteoblast lineage. Two different AR transgenic families (AR2.3-tg and AR3.6-tg mice) demonstrating overlapping and distinct expression profiles were employed to assess the effects of enhanced androgen sensitivity to ameliorate hypogonadal loss. Two different paradigm...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.08.111

    authors: Wiren KM,Zhang XW,Olson DA,Turner RT,Iwaniec UT

    更新日期:2012-11-01 00:00:00

  • Common herbs, essential oils, and monoterpenes potently modulate bone metabolism.

    abstract::During our survey of herbs looking for activity on bone metabolism, we found that the dried leaves of sage strongly inhibit bone resorption. Therefore, we investigated several common herbs rich in essential oils (sage, rosemary, and thyme) and essential oils extracted from these herbs and other plants (oils of sage, r...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(03)00027-9

    authors: Mühlbauer RC,Lozano A,Palacio S,Reinli A,Felix R

    更新日期:2003-04-01 00:00:00

  • Growth of new bone guided by implants in a murine calvarial model.

    abstract::New methods to increase vertical bone growth are needed to permit dental implant placement in patients with low alveolar ridge height after extended periods of tooth loss. While ectopic rodent models are typically used to evaluate new osteogenic implant surface coatings, a more relevant intramembraneous rodent model w...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2008.05.021

    authors: Freilich M,M Patel C,Wei M,Shafer D,Schleier P,Hortschansky P,Kompali R,Kuhn L

    更新日期:2008-10-01 00:00:00

  • No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.

    abstract::The aim of the study was to assess the biomechanical effects of short-term PTH treatment and withdrawal on bone mass and strength in an aged, osteopenic, ovariectomized (ovx) rat model. Additionally, the effect of sequential therapy with PTH and the bisphosphonate, risedronate, the effect of longterm PTH monotherapy, ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(97)00024-0

    authors: Mosekilde L,Thomsen JS,McOsker JE

    更新日期:1997-05-01 00:00:00

  • Apolipoprotein E-dependent inverse regulation of vertebral bone and adipose tissue mass in C57Bl/6 mice: modulation by diet-induced obesity.

    abstract::The long prevailing view that obesity is generally associated with beneficial effects on the skeleton has recently been challenged. Apolipoprotein E (apoE) is known to influence both adipose tissue and bone. The goal of the current study was to examine the impact of apoE on the development of fat mass and bone mass in...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.07.002

    authors: Bartelt A,Beil FT,Schinke T,Roeser K,Ruether W,Heeren J,Niemeier A

    更新日期:2010-10-01 00:00:00

  • Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

    abstract::Twenty patients with mild Paget's disease of bone were given either 20 (10 patients) or 40 mg alendronate daily for 6 months. The 20-mg dose was well tolerated, but in 3 patients on 40 mg/d alendronate, the treatment was withdrawn after 3-5 months because of gastric and oesophageal disturbances. Urinary hydroxyproline...

    journal_title:Bone

    pub_type: 临床试验,杂志文章

    doi:10.1016/8756-3282(94)90818-4

    authors: Adami S,Mian M,Gatti P,Rossini M,Zamberlan N,Bertoldo F,Lo Cascio V

    更新日期:1994-07-01 00:00:00

  • Mouse genetic model for bone strength and size phenotypes: NZB/B1NJ and RF/J inbred strains.

    abstract::The relationships of bone size, bone strength, and bone formation were investigated in two strains of mice, NZB/B1NJ and RF/J. Measurement of the femur midshaft size by peripheral quantitative computed tomography (pQCT) showed that the RF/J mice had a 32% greater cross-sectional area than NZB/B1NJ mice at 10 weeks of ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/s8756-3282(02)00908-0

    authors: Wergedal JE,Sheng MH,Ackert-Bicknell CL,Beamer WG,Baylink DJ

    更新日期:2002-12-01 00:00:00

  • Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.

    abstract:UNLABELLED:We evaluated the effect of glucocorticoids (GC) and growth hormone (GH) on cortical and cancellous bone turnover in adult rats using random vertical sections giving valid measurements of bone surfaces and bone formation parameters. GH administration could reverse GC-induced osteopenia and low bone turnover o...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2004.07.015

    authors: Ortoft G,Andreassen TT,Oxlund H

    更新日期:2005-01-01 00:00:00

  • The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption.

    abstract::Regulation of osteoclast differentiation and function is a central element in bone homeostasis. While the role of soluble factors, such as cytokines, hormones and growth factors, in controlling osteoclast differentiation has been intensively characterized, the function of surface receptors is less well understood. Sia...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115665

    authors: Andes FT,Adam S,Hahn M,Aust O,Frey S,Grueneboom A,Nitschke L,Schett G,Steffen U

    更新日期:2021-02-01 00:00:00

  • Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP).

    abstract:BACKGROUND:Fibrodysplasia ossificans progressiva (FOP) is a rare, disabling genetic disorder characterized by episodic soft tissue swelling (flare-ups) that leads to progressive heterotopic ossification and restricted joint mobility. METHODS:Here we present the first longitudinal patient-reported mobility assessment (...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2017.06.005

    authors: Kaplan FS,Al Mukaddam M,Pignolo RJ

    更新日期:2018-04-01 00:00:00

  • TNFalpha and PTH utilize distinct mechanisms to induce IL-6 and RANKL expression with markedly different kinetics.

    abstract::Parathyroid hormone (PTH) and tumor necrosis factoralpha (TNFalpha) are bone resorptive agents that upregulate interleukin-6 (IL-6) and RANKL production by osteoblasts. IL-6 mRNA expression induced by PTH is rapid and transient in osteoblasts both in vitro and in vivo. This study found that IL-6 secretion induced by P...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2005.10.007

    authors: Dai JC,He P,Chen X,Greenfield EM

    更新日期:2006-04-01 00:00:00

  • The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.

    abstract::Increases in local and systemic bone resorption are hallmarks of rheumatoid arthritis (RA). Osteoclasts are implicated in these processes and their enhanced differentiation may contribute to bone destruction. We observed that in vitro osteoclastogenesis varies among healthy individuals and hypothesized that increased ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2010.10.167

    authors: Durand M,Boire G,Komarova SV,Dixon SJ,Sims SM,Harrison RE,Nabavi N,Maria O,Manolson MF,Mizianty M,Kurgan L,de Brum-Fernandes AJ

    更新日期:2011-03-01 00:00:00

  • Ex vivo regional gene therapy with human adipose-derived stem cells for bone repair.

    abstract:BACKGROUND:The treatment of complex bone loss scenarios remains challenging. This study evaluates the efficacy of ex vivo regional gene therapy using transduced human adipose-derived stem cells (ASCs) overexpressing bone morphogenetic protein-2 (BMP-2) to treat critical-sized bone defects. METHODS:Critical-sized femor...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115524

    authors: Vakhshori V,Bougioukli S,Sugiyama O,Kang HP,Tang AH,Park SH,Lieberman JR

    更新日期:2020-09-01 00:00:00

  • Alveolar bone augmentation following the local administration of prostaglandin E1 by controlled-release pellets.

    abstract::E-Series prostaglandins (PGE) are powerful osteogenic substances when given in vivo. The purpose of this work was to determine the ability of locally administered PGE1 to promote alveolar bone formation. Controlled-release pellets containing PGE1 were implanted on the lateral mandibular surface of Beagle dogs and tiss...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(93)90198-j

    authors: Miller SC,Marks SC Jr

    更新日期:1993-05-01 00:00:00

  • Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia.

    abstract::Approximately 7.9 million fractures occur annually in the United States with 5-10% of these resulting in delayed or impaired healing. Nearly half of the trauma cost of $56 billion per year is used for the treatment of fractures. More importantly, fracture results in a substantial reduction in the quality of life. New ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2011.06.037

    authors: Bragdon B,Thinakaran S,Moseychuk O,Gurski L,Bonor J,Price C,Wang L,Beamer WG,Nohe A

    更新日期:2011-11-01 00:00:00

  • No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.

    abstract::Hypophosphatasia (HPP) is the inborn-error-of-metabolism characterized enzymatically by insufficient activity of the tissue-nonspecific isoenzyme of alkaline phosphatase (TNSALP) and caused by either mono- or bi-allelic loss-of-function mutation(s) of the gene ALPL that encodes this cell surface phosphomonoester phosp...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2019.02.025

    authors: Whyte MP,McAlister WH,Mumm S,Bierhals AJ

    更新日期:2019-05-01 00:00:00

  • Effects of minodronate on cortical bone response to mechanical loading in rats.

    abstract::The effects of BPs on bone formation during mechanical loading are still unknown. In this study, we evaluated the effect of minodronate on the cortical bone response to mechanical loading applied using a 4-point bending device. We used six-month old female Wistar rats and randomized into five groups (N=10/group): Vehi...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2012.11.026

    authors: Nagira K,Hagino H,Kameyama Y,Teshima R

    更新日期:2013-03-01 00:00:00

  • Parathyroid hormone therapy accelerates recovery from immobilization-induced osteopenia.

    abstract::Previous reports have shown that bone mass and architecture will partially recover by remobilization (RM) in immobilization (IM)-induced osteopenia. The aim of this study was to test whether PTH can accelerate the recovery during RM from the IM-induced osteopenia. Six-month-old Sprague-Dawley female rats were divided ...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/8756-3282(95)00295-o

    authors: Yuan ZZ,Jee WS,Ma YF,Wei W,Ijiri K

    更新日期:1995-10-01 00:00:00

  • Differences in the microarchitectural features of the lateral collapsed lesion between osteonecrosis and subchondral insufficiency fracture of the femoral head.

    abstract:BACKGROUND:Like osteonecrosis of the femoral head (ONFH), subchondral insufficiency fracture of the femoral head (SIF) causes femoral head collapse. However, little is known about the differences between the two diseases regarding the morphological features of the collapsed lesion. We tested the hypothesis that the mor...

    journal_title:Bone

    pub_type: 杂志文章

    doi:10.1016/j.bone.2020.115585

    authors: Kawano K,Motomura G,Ikemura S,Yamaguchi R,Baba S,Xu M,Nakashima Y

    更新日期:2020-12-01 00:00:00